Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | ste20-related kinase | 0.0355 | 0.6997 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0416 | 0.8751 | 0.8509 |
Leishmania major | protein kinase, putative | 0.0109 | 0 | 0.5 |
Trichomonas vaginalis | STE family protein kinase | 0.0211 | 0.2921 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0211 | 0.2921 | 1 |
Trypanosoma brucei | STE20-like serine/threonine-protein kinase 1, putative | 0.0109 | 0 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase 3 | 0.046 | 1 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase 3 | 0.046 | 1 | 1 |
Trypanosoma cruzi | STE/STE20 serine/threonine-protein kinase, putative | 0.0109 | 0 | 0.5 |
Trypanosoma cruzi | STE/STE20 serine/threonine-protein kinase, putative | 0.0109 | 0 | 0.5 |
Echinococcus multilocularis | serine threonine protein kinase | 0.0211 | 0.2921 | 0.2921 |
Trichomonas vaginalis | STE family protein kinase | 0.0211 | 0.2921 | 1 |
Plasmodium vivax | serine/threonine-specific protein kinase, putative | 0.0211 | 0.2921 | 0.5 |
Giardia lamblia | Kinase, STE STE20 | 0.0109 | 0 | 0.5 |
Loa Loa (eye worm) | STE/STE20/YSK protein kinase | 0.0211 | 0.2921 | 0.1551 |
Loa Loa (eye worm) | STE/STE20/MST protein kinase | 0.046 | 1 | 1 |
Echinococcus multilocularis | leucine rich repeat serine:threonine protein | 0.0416 | 0.8751 | 0.8751 |
Loa Loa (eye worm) | TKL/LRRK protein kinase | 0.0416 | 0.8751 | 0.8509 |
Plasmodium falciparum | protein kinase, putative | 0.0211 | 0.2921 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0211 | 0.2921 | 0.2418 |
Echinococcus granulosus | leucine rich repeat serine:threonine protein | 0.0419 | 0.8831 | 0.8348 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 20 % | Inhibition of C-terminal FLAG-tagged human recombinant autotaxin using synthetic substrate FS-3 at 10 uM measured every 2 mins by FRET assay relative to control | ChEMBL. | 23816044 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.